Osterman K, Norborg A M, Stähl E
Dept. of Lung Medicine, Karolinska Sjukhuset, Stockholm, Sweden.
Allergy. 1989 May;44(4):294-7. doi: 10.1111/j.1398-9995.1989.tb01073.x.
Nineteen patients with asthma completed an open, randomized, crossover study in which 0.5 mg terbutaline sulphate was administered either via Turbuhaler or via the metered dose inhaler (MDI) for 2-week periods. The clinical effect of the two treatment forms was comparable; both provided adequate bronchodilator therapy. Patients also considered Turbuhaler and MDI equally effective, with a small preference for the MDI. Turbuhaler seems to be a valuable alternative to bronchodilator MDI therapy.
19名哮喘患者完成了一项开放性随机交叉研究，该研究中，0.5毫克硫酸特布他林通过都保或定量吸入器（MDI）给药，为期2周。两种治疗方式的临床效果相当；两者都提供了足够的支气管扩张治疗。患者也认为都保和MDI同样有效，对MDI略有偏好。都保似乎是支气管扩张剂MDI治疗的一个有价值的替代方法。
